CD207+CD1a+ cells circulate in pediatric patients with active Langerhans cell histiocytosis-Reference-Cited by-同舟云学术

CD207+CD1a+ cells circulate in pediatric patients with active Langerhans cell histiocytosis

Published:2017-10-26 Issue:17 Volume:130 Page:1898-1902
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Carrera Silva Eugenio Antonio¹,Nowak Wanda²,Tessone Licina²,Olexen Cinthia Mariel¹²,Ortiz Wilczyñski Juan Manuel¹,Estecho Ivana Gisele²,Elena Graciela³,Errasti Andrea Emilse²,Rosso Diego Alfredo²³

Affiliation:

1. Instituto de Medicina Experimental, Academia Nacional de Medicina, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina;

2. Instituto de Farmacología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina; and

3. Hospital de Niños Pedro de Elizalde, Buenos Aires, Argentina

Abstract

Key Points CD207+CD1a+ cells are present in the circulation of patients with active LCH. TGF-β and TSLP levels are increased in the plasma of patients with active LCH.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/130/17/1898/1402930/blood782730.pdf

Reference18 articles.

1. Prognostic value of soluble interleukin 2 receptor levels in Langerhans cell histiocytosis;Rosso;Br J Haematol,2002

2. Pathogenesis of Langerhans cell histiocytosis;Badalian-Very;Annu Rev Pathol,2013

3. Langerhans cell histiocytosis: a clinicopathologic review and molecular pathogenetic update;Harmon;Arch Pathol Lab Med,2015

4. Symptomatic bone langerhans cell histiocytosis treated at diagnosis or after reactivation with indomethacin alone;Braier;J Pediatr Hematol Oncol,2014

5. Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis;Rosso;Br J Haematol,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating monocytes decrease significantly following disease-directed therapy and may reflect disease expansion in Langerhans Cell Histiocytosis;Annals of Hematology;2024-08-27

2. Increased AXLhigh myeloid cells as pathognomonic marker in Langerhans cell histiocytosis and Langerin expression dependence of mTOR inhibition;Clinical Immunology;2024-06

3. Circulating monocytes decrease significantly following disease-directed therapy and may reflect disease expansion in Langerhans Cell Histiocytosis;2024-04-04

4. Chlamydia trachomatis enhances HPV persistence through immune modulation;BMC Infectious Diseases;2024-02-20

5. The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives;Experimental Hematology & Oncology;2023-01-09